Cannara Biotech GAAP EPS of C$0.02, revenue of C$19.5M

Stock Information for Cannara Biotech Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cannara Biotech Inc.

CSE Bulletin: Fundamental Change - 12 Exploration Inc. (TWLV)
TransCanna Receives Approval To Begin Trading On The Frankfurt Stock Exchange
TransCanna's Affiliate TCM Distribution, Inc. Receives State of California Temporary Distributor License
Broadcom Inc. Completes Acquisition of CA Technologies
Research Report Identifies CA, Altra Industrial Motion, Forward Air, Franklin Street Properties, CME Group, and C.H. Robinson Worldwide with Renewed Outlook - Fundamental Analysis, Calculating Forward Movement
Keysight Technologies Set to Join S&P 500; Ligand Pharmaceuticals to Join S&P MidCap 400; Marcus & Millichap and Arcosa to Join S&P SmallCap 600
CA Technologies Updates Mainframe Solutions, Promoting an Open and Intelligent Platform for Hybrid Environments
NXP Semiconductors N.V. to Join the NASDAQ-100 Index Beginning November 5, 2018

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.